ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
The company filed its shareholding pattern reporting changes in share distribution following the recent open offer. The public shareholding has fallen below the minimum threshold.
Rekvina Laboratories Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending June 30, 2026. No changes in promoter control were disclosed.
Rekvina Laboratories Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026, as per regulatory requirements.
Rekvina Laboratories Ltd informed BSE that the requirement to submit an Annual Secretarial Compliance Report for FY2026 is not applicable. The company claims exemption under Regulation 15(2) of SEBI LODR as its paid-up equity capital and net worth remain below the prescribed thresholds of ₹10 Crore and ₹25 Crore respectively.
Rekvina Laboratories Ltd submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018. For the period ended March 31, 2026, the company reported nil share certificates were received for dematerialisation. This is a routine regulatory disclosure with no material financial impact.